65 related articles for article (PubMed ID: 23542086)
1. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
Luers C; Sutcliffe A; Binder L; Irle S; Pieske B
Clin Biochem; 2013 Aug; 46(12):1013-1019. PubMed ID: 23542086
[TBL] [Abstract][Full Text] [Related]
2. Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction.
Cui K; Huang W; Fan J; Lei H
Medicine (Baltimore); 2018 Sep; 97(36):e12277. PubMed ID: 30200170
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.
Cameron AC; Arnold M; Katsas G; Yang J; Quinn TJ; Abdul-Rahim AH; Campbell R; Docherty K; De Marchis GM; Arnold M; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Foerch C; Spanaus K; Eckardstein AV; Dawson J; Katan M
Neurology; 2024 Aug; 103(3):e209625. PubMed ID: 38950311
[TBL] [Abstract][Full Text] [Related]
4. NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease.
Shimohata H; Usui J; Tawara-Iida T; Ebihara I; Ishizu T; Maeda Y; Kobayashi H; Numajiri D; Kaneshige A; Sega M; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M; Yamagata K;
Clin Exp Nephrol; 2024 May; 28(5):457-464. PubMed ID: 38238500
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke.
García-Carmona JA; Conesa-García E; Vidal-Mena D; González-Morales M; Ramos-Arenas V; Sánchez-Vizcaíno-Buendía C; Soria-Torrecillas JJ; Pérez-Vicente JA; García-de-Guadiana-Romualdo L
Neurologia (Engl Ed); 2024; 39(6):496-504. PubMed ID: 38901926
[TBL] [Abstract][Full Text] [Related]
6. Heart rhythm turbulence and NT-proBNP in decompensated liver cirrhosis--a pilot study.
Poliwczak AR; Białkowska J; Broncel M; Koziróg M; Dworniak K; Kotecka K; Jabłkowski M
Med Sci Monit; 2011 Jun; 17(6):PR5-11. PubMed ID: 21629202
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of NT-proBNP as a prognostic factor for septic shock patients presenting to the emergency department.
Choi Y; Lee JH
Sci Rep; 2024 May; 14(1):10999. PubMed ID: 38744896
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.
Parcha V; Patel N; Kalra R; Arora G; Januzzi JL; Felker GM; Wang TJ; Arora P
Circulation; 2020 Sep; 142(10):1018-1020. PubMed ID: 32897749
[TBL] [Abstract][Full Text] [Related]
9. Cluster analysis of volatile organic compounds - A pilot study in patients with severe acute decompensated heart failure.
Butter L; Haase-Fielitz A; Zänker M; Becher G; Nübel J; Butter C
J Cardiol; 2024 Aug; 84(2):146-148. PubMed ID: 38621579
[TBL] [Abstract][Full Text] [Related]
10. Associations of atrial natriuretic peptide with measures of insulin and adipose depots.
Couch CA; Fowler LA; Parcha V; Arora P; Gower BA
Physiol Rep; 2023 Mar; 11(5):e15625. PubMed ID: 36905117
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies.
Montellano FA; Rücker V; Ungethüm K; Penalba A; Hotter B; Giralt M; Wiedmann S; Mackenrodt D; Morbach C; Frantz S; Störk S; Whiteley WN; Kleinschnitz C; Meisel A; Montaner J; Haeusler KG; Heuschmann PU
Eur Stroke J; 2024 May; ():23969873241250272. PubMed ID: 38711254
[TBL] [Abstract][Full Text] [Related]
12. Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.
Myhre PL; Omland T; Shah AM
Circ Heart Fail; 2024 Feb; 17(2):e011428. PubMed ID: 38299326
[No Abstract] [Full Text] [Related]
13. The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects.
Gruson D; Hammerer-Lercher A; Collinson P; Duff C; Baum H; Pulkki K; Suvisaari J; Stankovic S; Laitinen P; Bayes-Genis A
Crit Rev Clin Lab Sci; 2024 Mar; ():1-15. PubMed ID: 38523480
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Length of Hospital Stay And In-Hospital Adverse Events in Patients With Acute Decompensated Heart Failure: In-hospital 24-Hour Blood Pressure Monitoring Data.
Candemir M; Kızıltunç E; Nurkoç SG; Cihan B; Şahinarslan A
Hellenic J Cardiol; 2024 Jun; ():. PubMed ID: 38925251
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence universal biomarker prediction tool.
Takefuji Y
J Thromb Thrombolysis; 2024 Feb; 57(2):341-343. PubMed ID: 38117437
[TBL] [Abstract][Full Text] [Related]
16. Is it NICE to measure natriuretic peptides after a hospitalization for heart failure?
Pagnesi M; Adamo M; Metra M
Eur J Heart Fail; 2024 Apr; 26(4):785-787. PubMed ID: 38654473
[No Abstract] [Full Text] [Related]
17. The influence of integrated healthcare on the nursing effect, negative emotions, and heart failure indicators in acute heart failure patients.
Guan H; Wang L; Zhu B; Liu Y; Ji J
Am J Transl Res; 2021; 13(6):6694-6701. PubMed ID: 34306414
[TBL] [Abstract][Full Text] [Related]
18. Dynamic assessment of atrial function in decompensated heart failure.
Sánchez ME; Panno MA; Etchegoyen CV
Acta Cardiol; 2024 Apr; ():1-2. PubMed ID: 38646943
[No Abstract] [Full Text] [Related]
19. Diagnostic tests and referral pathway of patients with diagnosis of heart failure in an acute admission unit.
Mak H
Future Healthc J; 2023 Nov; 10(Suppl 3):103-104. PubMed ID: 38406675
[No Abstract] [Full Text] [Related]
20. Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.
Fu S; Ping P; Wang F; Luo L
J Biol Eng; 2018; 12():2. PubMed ID: 29344085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
